Holdings
Ikarian Capital, LLC
As of Jun 30, 2026, Ikarian Capital, LLC reported 112 positions worth US$581M. Largest: Abivax Sa, Kodiak Sciences Inc and Alumis Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abivax Sa | 329K | US$43.4M | +271K | Jun 30, 2026 |
| Kodiak Sciences Inc | 1.06M | US$41.3M | −206K | Jun 30, 2026 |
| Alumis Inc. | 871K | US$24.5M | −343K | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 72,842 | US$24.4M | +1,261 | Jun 30, 2026 |
| Vaxcyte, Inc. | 389K | US$22.6M | −40,000 | Jun 30, 2026 |
| Ani Pharmaceuticals, Inc. | 272K | US$22.5M | +125K | Jun 30, 2026 |
| Celldex Therapeutics, Inc. | 479K | US$17.8M | +17,253 | Jun 30, 2026 |
| Arcus Biosciences, Inc. | 505K | US$15.6M | new | Jun 30, 2026 |
| Relmada Therapeutics, Inc. | 2.15M | US$14.9M | −540K | Jun 30, 2026 |
| Capricor Therapeutics, Inc. | 604K | US$14.5M | +76,200 | Jun 30, 2026 |